MannKind Corporation announced that the FDA has approved Afrezza (insulin human) Inhalation Powder to improve glycemic control in adult patients...
Mannkind Corp has resubmitted its new drug application to the FDA seeking approval for Afrezza (insulin human [rDNA origin]) Inhalation...
MannKind Corporation announced positive preliminary results from Study 171, a Phase III clinical study of Afrezza (insulin human [rDNA origin])...
MannKind Corporation has announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 13 to 1 to...
Sanofi and MannKind Corporation have announced that they have entered into a worldwide exclusive licensing agreement for development and commercialization...